Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAR | AMGN | VRTX | GILD | BMY |
| Company | Pharming Group N.V. ADR | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 9.43 | 269.33 | 415.13 | 91.35 | 56.13 |
| High | 9.53 | 272.82 | 422.79 | 92.59 | 56.74 |
| Low | 9.43 | 269.04 | 415.13 | 91.04 | 55.66 |
| Last | 9.52 | 270.35 | 420.00 | 91.97 | 56.00 |
| Change | -0.41 | +3.25 | +8.34 | +0.97 | +0.26 |
| % Change | -4.13% | +1.22% | +2.03% | +1.07% | +0.47% |
| Volume | 875 | 912,687 | 402,621 | 2,504,312 | 2,448,993 |
| 20-Day Average Volume | 5,664 | 3,488,295 | 2,021,194 | 6,202,616 | 11,048,245 |
| Previous Close | 9.93 | 267.10 | 411.66 | 91.00 | 55.74 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.72 | 263.22 | 415.21 | 91.83 | 56.74 |
| 20-Day Raw Stochastic | 45.23% | 83.15% | 43.85% | 59.62% | 36.41% |
| 20-Day Relative Strength | 52.81% | 45.91% | 44.20% | 53.03% | 48.15% |
| Weighted Alpha | -12.07 | -15.47 | -7.88 | +15.86 | +17.24 |
| Today's Opinion | 72% Buy | 88% Sell | 72% Sell | 80% Buy | 40% Buy |
| Previous Opinion | 80% Buy | 88% Sell | 88% Sell | 56% Buy | 40% Buy |
| Last Month's Opinion | 24% Buy | 88% Sell | 24% Sell | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.96% since 01/07/25 | +2.85% since 01/07/25 | +2.88% since 01/07/25 | +1.66% since 01/07/25 | -1.70% since 01/07/25 |
| Low | 9.14 on 01/13/25 | 259.82 on 01/08/25 | 397.24 on 01/13/25 | 88.57 on 01/10/25 | 54.81 on 01/13/25 |
| High | 10.15 on 01/13/25 | 272.82 on 01/15/25 | 422.67 on 01/15/25 | 92.58 on 01/15/25 | 57.05 on 01/08/25 |
| 1-Month | |||||
| %Chg | +5.99% since 12/13/24 | -0.40% since 12/13/24 | -9.41% since 12/13/24 | +0.30% since 12/13/24 | +0.70% since 12/13/24 |
| Low | 8.24 on 12/19/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 88.57 on 01/10/25 | 54.81 on 01/13/25 |
| High | 11.07 on 12/26/24 | 272.82 on 01/15/25 | 474.18 on 12/17/24 | 94.55 on 12/26/24 | 58.54 on 12/18/24 |
| 3-Month | |||||
| %Chg | +9.43% since 10/15/24 | -17.09% since 10/15/24 | -13.26% since 10/15/24 | +7.36% since 10/15/24 | +6.46% since 10/15/24 |
| Low | 7.31 on 11/21/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 85.60 on 10/22/24 | 51.81 on 10/28/24 |
| High | 11.07 on 12/26/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | +9.30% since 07/15/24 | -18.36% since 07/15/24 | -14.42% since 07/15/24 | +30.12% since 07/15/24 | +39.90% since 07/15/24 |
| Low | 6.65 on 07/29/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 70.33 on 07/16/24 | 40.09 on 07/16/24 |
| High | 11.07 on 12/26/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 673,602 | 143,575,072 | 106,014,392 | 113,410,208 | 113,050,592 |
| Shares Outstanding, K | 67,835 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 245,320,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -10,550,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 74,850,000 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -1,030,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | -0.08 | 0.56 | 0.40 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 10/24/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 10/24/24 | 02/04/25 | 02/03/25 | 02/11/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.620 on 01/03/25 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.06 | 0.00 | 20.30 | 47.32 |